Synthekine
Deepti Rokkam is an experienced professional in antibody engineering, currently serving as Director at Synthekine since May 2019, previously holding roles as Associate Director and Principal Scientist. Prior experience includes positions at AbbVie Stemcentrx as Sr. Scientist and Scientist II, where responsibilities encompassed single B-cell sorting, sequencing, and data analysis, along with yeast and phage display techniques. At Sutro Biopharma, Inc., Deepti worked as a Research Associate in Protein Engineering, focusing on ribosome display and antibody drug conjugation. Early career roles involved research at NCIRE - The Veterans Health Research Institute and Children's Hospital Oakland Research Institute, with significant contributions to projects involving cell culture, microscopy, and genetic sequencing. Deepti holds an MS in Cell/Cellular and Molecular Biology from California State University - East Bay and a Bachelor's in Dental Surgery from Sri Ramachandra Medical College and Research Institute.
This person is not in any teams
This person is not in any offices
Synthekine
3 followers
Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders.